Veeva Systems (VEEV) Receives a Buy from TD Cowen
In a report released today, Charles Rhyee from TD Cowen maintained a Buy rating on Veeva Systems, with a price target of $300.00.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Rhyee is a 4-star analyst with an average return of 3.2% and a 50.61% success rate. Rhyee covers the Healthcare sector, focusing on stocks such as Cardinal Health, Medline, and Option Care Health.
In addition to TD Cowen, Veeva Systems also received a Buy from TipRanks – Anthropic’s Anthropic Medical – Healthcare Information Services in a report issued today. However, on the same day, Morgan Stanley maintained a Hold rating on Veeva Systems (NYSE: VEEV).
Based on Veeva Systems’ latest earnings release for the quarter ending October 31, the company reported a quarterly revenue of $811.24 million and a net profit of $236.2 million. In comparison, last year the company earned a revenue of $699.21 million and had a net profit of $185.81 million
Read More on VEEV:
Disclaimer & DisclosureReport an Issue
- Strong Near-Term Execution but Uncertain Long-Term Growth Drivers Justify Hold on Veeva
- Veeva price target lowered to $317 from $333 at Wells Fargo
- Closing Bell Movers: Veeva up 13%, Broadcom up 5% on earnings beat
- Veeva reports Q4 non-GAAP EPS $2.06, consensus $1.94
- Veeva sees Q1 non-GAAP EPS $2.131-$2.14, consensus $2.06
